Researchers from the AIDS Research Institute (IrsiCaixa) participated in a study led by Harvard University that indicates that some HIV-positive individuals have a one of variety of strains that are resistant to antiretroviral drugs and are not detectable by routine resistance testing

STAFF | APRIL 6TH, 2011

A new drug, eribulin, has proven effective for treating metastatic breast cancer and increases survival rates by 20%, according to a study by the Vall d'Hebron Research Institute published in The Lancet. The aim is to apply the drug to advanced cases of the disease for which other treatments have failed

STAFF | MARCH 4TH, 2011

A study led by Manel Esteller of Barcelona’s Institute of Biomedical Research of Bellvitge has identified a drug that inhibits cancer growth by activating the genome’s so-called “dark matter” (or non-coding DNA) and microRNA molecules. The study is published in Proceedings of the National Academy of Sciences

STAFF | MARCH 2ND, 2011

Although antibiotics have been used since the 40s to combat TB, the bacteria that causes it eventually develops resistance against these drugs, which are becoming less effective.

Staff | 22 March 2010